X

Nintedanib

Scotland: Hope for patients with pulmonary fibrosis

The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland…

Victory for thousands of terminally ill patients

Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than…

This website uses cookies.